1-11 of 11
Marco Donia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 900: Melanoma immune escape controlled by cancer cell-intrinsic STING signaling is linked to MHC-I suppression

Lea Skovmand Jensen, Anne Weiss, Arianna Draghi, Shawez Khan, Aida Solhøj Hansen, Anders Etzerodt, Bent Winding Deleuran, Marco Donia, Martin Roelsgaard Jakobsen
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 900.
https://doi.org/10.1158/1538-7445.AM2025-900
Published: 21 April 2025
View articletitled, Abstract 900: Melanoma immune escape controlled by cancer cell-intrinsic STING signaling is linked to MHC-I suppression
Journal Articles

Abstract 1: Biomarkers of response and acquired resistance to TIL-ACT in solid tumors

Welles Robinson, Andrea Castro, Maise Al-Bakir, Jared J. Gartner, Christopher Aled Chamberlain, Anders H. Kverneland, Troels H. Borch, Inge Marie Svane, Marco Donia, Paul Robbins, Kevin Litchfield
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1.
https://doi.org/10.1158/1538-7445.AM2024-1
Published: 22 March 2024
View articletitled, Abstract 1: Biomarkers of response and acquired resistance to TIL-ACT in solid tumors
Journal Articles

Abstract CT535: High clinical efficacy in poor prognosis patients with metastatic melanoma treated with an IDO/PD-L1 peptide vaccine in combination with nivolumab

Julie W. Kjeldsen, Cathrine L. Lorentzen, Evelina Martinenaite, Eva Ellebaek, Marco Donia, Eva Ehrnrooth, Mads H. Andersen, Inge Marie Svane
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT535.
https://doi.org/10.1158/1538-7445.AM2022-CT535
Published: 15 June 2022
View articletitled, Abstract CT535: High clinical efficacy in poor prognosis patients with metastatic melanoma treated with an IDO/PD-L1 peptide vaccine in combination with nivolumab
Journal Articles

Abstract 386: Evaluation of CPa9-HNE - a peripheral biomarker based on neutrophil extracellular traps (NETs) - for predicting outcome in patients with metastatic melanoma treated with anti-PD-1 therapy

Christina Jensen, Anders Kverneland, Marco Donia, Joachim H. Mortensen, Morten A. Karsdal, Inge Marie Svane, Nicholas Willumsen
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 386.
https://doi.org/10.1158/1538-7445.AM2021-386
Published: 01 July 2021
View articletitled, Abstract 386: Evaluation of CPa9-HNE - a peripheral biomarker based on neutrophil extracellular traps (NETs) - for predicting outcome in patients with metastatic melanoma treated with anti-PD-1 therapy
Journal Articles

Abstract 388: Non-invasive biomarker potential of the fibroblast-derived collagen type III and collagen type XI for predicting outcome in metastatic melanoma patients treated with anti-PD-1 therapy

Christina Jensen, Anders Kverneland, Marco Donia, Neel I. Nissen, Morten A. Karsdal, Inge Marie Svane, Nicholas Willumsen
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 388.
https://doi.org/10.1158/1538-7445.AM2021-388
Published: 01 July 2021
View articletitled, Abstract 388: Non-invasive biomarker potential of the fibroblast-derived collagen type III and collagen type XI for predicting outcome in metastatic melanoma patients treated with anti-PD-1 therapy
Journal Articles

Abstract 3185: CAR-T cells can eradicate human uveal melanoma and immune-therapy resistant malignant melanoma in IL-2 transgenic NOD/SCID IL2 receptor gamma knockout mice

Elin Forsberg, Mattias Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, Marco Donia, Inge Marie Svane, Ola Nilsson, Lars Ny, Lisa Nilsson, Jonas Nilsson
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3185.
https://doi.org/10.1158/1538-7445.AM2019-3185
Published: 01 July 2019
View articletitled, Abstract 3185: CAR-T cells can eradicate human uveal melanoma and immune-therapy resistant malignant melanoma in IL-2 transgenic NOD/SCID IL2 receptor gamma knockout mice
Journal Articles

HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice

Elin M.V. Forsberg, Mattias F. Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, Marco Donia, Inge Marie Svane, Ola Nilsson, Lars Ny, Lisa M. Nilsson, Jonas A. Nilsson
Journal: Cancer Research
Cancer Res (2019) 79 (5): 899–904.
https://doi.org/10.1158/0008-5472.CAN-18-3158
Published: 01 March 2019
View articletitled, HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice
Open the PDF for HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice in another window
Includes: Supplementary data
Journal Articles

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

Marco Donia, Katja Harbst, Marit van Buuren, Pia Kvistborg, Mattias F. Lindberg, Rikke Andersen, Manja Idorn, Shamaila Munir Ahmad, Eva Ellebæk, Anja Mueller, Paolo Fagone, Ferdinando Nicoletti, Massimo Libra, Martin Lauss, Sine Reker Hadrup, Henrik Schmidt, Mads Hald Andersen, Per thor Straten, Jonas A. Nilsson, Ton N. Schumacher, Barbara Seliger, Göran Jönsson, Inge Marie Svane
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4562–4566.
https://doi.org/10.1158/0008-5472.CAN-16-3172
Published: 31 August 2017
View articletitled, Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
Open the PDF for Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling in another window
Includes: Supplementary data
Journal Articles

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

Marco Donia, Rikke Andersen, Julie W. Kjeldsen, Paolo Fagone, Shamaila Munir, Ferdinando Nicoletti, Mads Hald Andersen, Per thor Straten, Inge Marie Svane
Journal: Cancer Research
Cancer Res (2015) 75 (18): 3747–3759.
https://doi.org/10.1158/0008-5472.CAN-14-2956
Published: 14 September 2015
View articletitled, Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Open the PDF for Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity in another window
Includes: Supplementary data
Journal Articles

HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

Shamaila Munir, Gitte Holmen Andersen, Özcan Met, Marco Donia, Thomas Mørch Frøsig, Stine Kiaer Larsen, Tobias Wirenfeldt Klausen, Inge Marie Svane, Mads Hald Andersen
Journal: Cancer Research
Cancer Res (2013) 73 (6): 1764–1776.
https://doi.org/10.1158/0008-5472.CAN-12-3507
Published: 14 March 2013
View articletitled, HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
Open the PDF for HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Dissection of T-cell Antigen Specificity in Human Melanoma

Rikke Sick Andersen, Charlotte Albæk Thrue, Niels Junker, Rikke Lyngaa, Marco Donia, Eva Ellebæk, Inge Marie Svane, Ton N. Schumacher, Per thor Straten, Sine Reker Hadrup
Journal: Cancer Research
Cancer Res (2012) 72 (7): 1642–1650.
https://doi.org/10.1158/0008-5472.CAN-11-2614
Published: 01 April 2012
View articletitled, Dissection of T-cell Antigen Specificity in Human Melanoma
Open the PDF for Dissection of T-cell Antigen Specificity in Human Melanoma in another window
Includes: Supplementary data